8-K
filed March 18, 2026, 7:59 PM ET
ticker ARTL
CIK 0001621221
debt
confidence high
sentiment neutral
materiality 0.60
Artelo Biosciences raises $310k via 12% bridge notes with default conversion feature
ARTELO BIOSCIENCES, INC.
- Issued two 12% bridge notes totaling $350,300 principal ($237,300 Vanquish + $113,000 Boot) for net proceeds of $310,000 after $40,300 OID.
- Notes mature Jan 15, 2027; company may prepay at any time with no penalty.
- Upon default, notes can convert into common shares at the higher of $0.125 or 75% of the 10-day VWAP; conversion capped at 4.99% beneficial ownership per holder.
- Proceeds used for general working capital; Company reimbursed Vanquish $10,000 in fees.
- Securities issued under Regulation D, Section 4(a)(2); represented as accredited investors only.
Key facts
Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
ARTELO BIOSCIENCES, INC. issued convertible note to Vanquish Funding Group Inc. for aggregate principal amount of $237,300.00, which includes an original issue discount of $27,300.00, for an aggregate purchase price of $210,000.00.
- Security
- convertible note
- Purchaser
- Vanquish Funding Group Inc.
- Consideration
- aggregate principal amount of $237,300.00, which includes an original issue discount of $27,300.00, for an aggregate purchase price of $210,000.00
Exact text from the filing
Agreement”), with Vanquish Funding Group Inc., a Virginia corporation (“Vanquish”), pursuant to which the Company issued a 12% bridge note in the aggregate principal amount of $237,300.00, which includes an original issue discount of $27,300.00, for an aggregate purchase price of $210,000.00 (the “Vanquish Note”). Additionally, on March 12, 2026, the Company
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
ARTELO BIOSCIENCES, INC. issued convertible note to Boot Capital LLC for aggregate principal amount of $113,000.00, which includes an original issue discount of $13,000.00, for an aggregate purchase price of $100,000.00.
- Security
- convertible note
- Purchaser
- Boot Capital LLC
- Consideration
- aggregate principal amount of $113,000.00, which includes an original issue discount of $13,000.00, for an aggregate purchase price of $100,000.00
Exact text from the filing
limited liability company (“Boot” and together with Vanquish , the “Buyers”), pursuant to which the Company issued a 12% bridge note in the aggregate principal amount of $113,000.00, which includes an original issue discount of $13,000.00, for an aggregate purchase price of $100,000.00 (the “Boot Note” and together with the Vanquish Note, the “Notes”). The
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
ARTELO BIOSCIENCES, INC. entered into Vanquish Purchase Agreement with Vanquish Funding Group Inc. valued at $210,000.00 (effective 2026-03-12).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Vanquish Funding Group Inc.
- Value
- $210,000.00
- Effective
- 2026-03-12
Exact text from the filing
On March 12, 2026, Artelo Biosciences, Inc. (the “Company”) entered into a Securities Purchase Agreement, dated as of March 12, 2026 (the “Vanquish Purchase Agreement”), with Vanquish Funding Group Inc., a Virginia corporation (“Vanquish”), pursuant to which the Company issued a 12% bridge note in the aggregate principal amount of $237,300.00, which includes an original issue discount of $27,300.00, for an aggregate purchase price of $210,000.00 (the “Vanquish Note”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
ARTELO BIOSCIENCES, INC. entered into Boot Purchase Agreement with Boot Capital LLC valued at $100,000.00 (effective 2026-03-12).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Boot Capital LLC
- Value
- $100,000.00
- Effective
- 2026-03-12
Exact text from the filing
Additionally, on March 12, 2026, the Company entered into a Securities Purchase Agreement, dated as of March 12, 2026 (the “Boot Purchase Agreement” and together with the Vanquish Purchase Agreement, the “Purchase Agreements”), with Boot Capital LLC, a Delaware limited liability company (“Boot” and together with Vanquish , the “Buyers”), pursuant to which the Company issued a 12% bridge note in the aggregate principal amount of $113,000.00, which includes an original issue discount of $13,000.00, for an aggregate purchase price of $100,000.00 (the “Boot Note” and together with the Vanquish Note, the “Notes”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.